AvroBio, Inc
1 known investors
Find your way into AvroBio, Inc
AVROBIO develops ex vivo lentiviral vector-based hematopoietic stem cell gene therapies to treat lysosomal disorders by permanently integrating therapeutic genes into patient stem cells manufactured outside the body. The modified cells differentiate into multiple cell types capable of crossing the blood-brain barrier to deliver treatment throughout the body and central nervous system.
Investors · 1
Frequently asked questions
- What does AvroBio, Inc do?
- AVROBIO develops ex vivo lentiviral vector-based hematopoietic stem cell gene therapies to treat lysosomal disorders by permanently integrating therapeutic genes into patient stem cells manufactured outside the body. The modified cells differentiate into multiple cell types capable of crossing the blood-brain barrier to deliver treatment throughout the body and central nervous system.
- Who are AvroBio, Inc's investors?
- AvroBio, Inc's investors include SV Health Investors.